Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action modulators |
Mechanism P2Y12 receptor modulators(Purinergic receptor P2Y12 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroinflammation | Preclinical | France | 27 Sep 2024 |